LAUSR

Background Owing to recent advances in cancer therapy, updated data are required for clinicians counselling patients on treatment of spinal metastases. Objective To analyse the outcomes of surgical treatments of spinal metastases. Methods Prospective and multicentric study that included consecutively patients operated on for spinal metastases between January 2016 and January 2017. Overall survival was calculated with the Kaplan-Meier method. Cox proportional hazard model was used to calculate hazard ratio (HR) analysing mortality risk according to preoperative Karnofsky performance status (KPS), mobility level and neurological status. Results A total of 252 patients were included (145 males, 107 females) aged a mean 63.3 years. Median survival was 450 days. Primary cancer sites were lung (21%) and breast (19%). Multiple spinal metastases involved 122 patients (48%). Concomitant skeletal and visceral metastases were noted in 90 patients (36%). Main procedure was laminectomy and posterior fixation (57%). Overall, pain and mobility level were improved postoperatively. Most patients had normal preoperative motor function (50%) and remained so postoperatively. Patients “bedbound” on admission were the less likely to recover. In-hospital death rate was 2.4% (three disease progression, one septic shock, one pneumonia, one pulmonary embolism). Complication rate was 33%, deep wound infection was the most frequent aetiology. Higher mortality was observed in patients with poorest preoperative KPS (KPS 0–40%, HR = 3.1, p  < 0.001) and mobility level (“bedbound”, HR = 2.16, p  < 0.001). Survival seemed also to be linked to preoperative neurological function. Conclusion Surgical treatments helped maintain reasonable condition for patients with spinal metastases. Intervention should be offered before patients’ condition worsen to ensure better outcomes.